Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orthofix Medical Inc. | 90,809 | reported | 07 May 2026 | tx 5+67,399 |
| NEWLINK GENETICS CORP | 55,052 | reported | 01 Oct 2018 | tx 21+738,591−15,710 |
| Anika Therapeutics, Inc. | 54,871 | reported | 01 May 2026 | tx 8+54,871 |
| INTEGRA LIFESCIENCES HOLDINGS CORP | 34,159 | reported | 25 Aug 2014 | tx 276+1,047,679−1,342,398 |
| Aprea Therapeutics, Inc. | 4,185 | reported | 05 Jun 2025 | tx 16+118,617 |
| R1 RCM Inc. /DE | 0 | reported | 19 Nov 2024 | tx 35+715,479−703,480 |
| Accretive Health, Inc. | 0 | reported | 21 Jun 2022 | tx 73+644,055−644,055 |
| SeaSpine Holdings Corp | 0 | reported | 05 Jan 2023 | tx 21+170,098−196,389 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | PURCHASE | Orthofix Medical Inc. | 5,000 | 12.26 USD | |
| 01 May 2026 | PURCHASE | Anika Therapeutics, Inc. | 5,000 | 14.66 USD | first after silence |
| 20 Jun 2025 | GRANT_AWARD | Anika Therapeutics, Inc. | 14,164 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | Orthofix Medical Inc. | 18,841 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 1,045 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,185 | 0.00 USD | deriv |
| 19 Nov 2024 | OTHER | R1 RCM Inc. /DE | 87,765 | 14.30 USD | |
| 19 Nov 2024 | OTHER | R1 RCM Inc. /DE | 515,715 | — | deriv |
| 09 Jul 2024 | GRANT_AWARD | Anika Therapeutics, Inc. | 5,771 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 1,045 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,185 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Orthofix Medical Inc. | 15,152 | 12.87 USD | |
| 23 May 2024 | GRANT_AWARD | R1 RCM Inc. /DE | 15,651 | 0.00 USD | |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 6,860 | 7.29 USD | |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 3,430 | — | derivfirst after silence |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 3,430 | — | deriv |
| 23 Aug 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 500 | 0.00 USD | |
| 23 Aug 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 2,000 | 0.00 USD | deriv |
| 08 Aug 2023 | SALE | R1 RCM Inc. /DE | 50,000 | 17.17 USD | |
| 08 Aug 2023 | EXERCISE | R1 RCM Inc. /DE | 50,000 | 2.61 USD | |
| 08 Aug 2023 | EXERCISE | R1 RCM Inc. /DE | 50,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Anika Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 18 May 2023 | GRANT_AWARD | R1 RCM Inc. /DE | 11,324 | 0.00 USD | |
| 05 Jan 2023 | OTHER | SeaSpine Holdings Corp | 82,654 | — | |
| 05 Jan 2023 | OTHER | SeaSpine Holdings Corp | 13,920 | — | deriv |
5 purchases reported after at least 12 months of silence — most recent on 01 May 2026.